Use of alfuzosin 10 mg once daily increases the likelihood of a successful trial without catheter (TWOC) after acute urinary retention (AUR) secondary to benign prostatic hyperplasia (BPH), according ...

May 25, 2006 — Three new studies presented here at the 2006 annual meeting of the American Urological Association support the use of phosphodiesterase-5 (PDE-5) inhibitors for the resolution of lower ...

Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.

Patients who receive alfuzosin as treatment for benign prostatic hyperplasia (BPH) experience improvements in sexual function as well lower urinary tract symptoms (LUTS), a South Korean study suggests ...

A consistently effective treatment is unlikely to emerge until we gain better understanding of this condition. Although chronic prostatitis (now called "chronic prostatitis-chronic pelvic pain ...